BSE filing, NSE: CAPRO. Summary written from the filing by ALFA Finder's alert engine.
Caprolactam Chemicals Ltd: key numbers
- Share price
- ₹50.00
- Market cap
- ₹23.00 Cr
- Revenue (annual)
- ₹10.56 Cr
- Net profit (annual)
- ₹1.76 Cr
- P/E (TTM)
- 56.1×Sector 34.1×
- Promoter holding
- 54.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Caprolactam Chemicals Ltd
All →Caprolactam Chemicals Board Meeting Date
Caprolactam Chemicals will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window is closed from 1 October 2026.
Caprolactam Chemicals Other Announcement
Caprolactam Chemicals Ltd has filed its quarterly shareholding pattern report under Regulation 31(1)(b) of the SEBI LODR Regulations for the period ended 30 September 2026.
Caprolactam Chemicals Annual General Meeting
Caprolactam Chemicals Ltd. held its 37th Annual General Meeting on September 28, 2026. Shareholders considered routine items, including financial statements and the appointment of statutory auditors.
Caprolactam Chemicals Other Announcement
Caprolactam Chemicals Ltd. has appointed M/s. Raman S. Shah & Co. as the company's Statutory Auditor for a term of 60 months.
Caprolactam Chemicals Management Change
Caprolactam Chemicals internal auditor Shrey Pandey & Associates resigned effective 10 Sept 2026. Parth Patel D & Associates was appointed as the new internal auditor for FY 2026-27.
Caprolactam Chemicals Annual General Meeting
Caprolactam Chemicals Ltd. has issued a notice for its 37th Annual General Meeting to be held on September 28, 2026, through video conference.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.